SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-18-003699
Filing Date
2018-05-09
Accepted
2018-05-09 07:45:57
Documents
52
Period of Report
2018-05-09

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_050918.htm 6-K 9439
2 EXHIBIT 99.1 exh_991.htm EX-99.1 165251
3 EXHIBIT 99.2 exh_992p.htm EX-99.2 268558
10 GRAPHIC fs_graphic.jpg GRAPHIC 26769
  Complete submission text file 0001171843-18-003699.txt   2766712

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE cmta-20180331.xml EX-101.INS 469162
5 XBRL SCHEMA FILE cmta-20180331.xsd EX-101.SCH 52469
6 XBRL CALCULATION FILE cmta-20180331_cal.xml EX-101.CAL 29398
7 XBRL DEFINITION FILE cmta-20180331_def.xml EX-101.DEF 211238
8 XBRL LABEL FILE cmta-20180331_lab.xml EX-101.LAB 220064
9 XBRL PRESENTATION FILE cmta-20180331_pre.xml EX-101.PRE 231414
Mailing Address 4150 ST CATHERINE STREET WEST SUITE 550 MONTREAL A8 H3Z 2Y5
Business Address 4150 ST CATHERINE STREET WEST SUITE 550 MONTREAL A8 H3Z 2Y5 (514) 940-3600
Clementia Pharmaceuticals Inc. (Filer) CIK: 0001647320 (see all company filings)

IRS No.: 981128564 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38177 | Film No.: 18816695
SIC: 2834 Pharmaceutical Preparations